clinical trial · NCT06819774
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Shandong New Time Pharmaceutical Co., LTD·phase3·recruiting·n = 284
Acute UrticariaCetirizine Hydrochloride InjectionDiphenhydramine Hydrochloride Injection
brief summary
The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.
started
Apr 22, 2024
primary completion
Aug 1, 2025
completion
Aug 1, 2025
last updated
Feb 11, 2025
official title
Efficacy and Safety of Cetirizine Hydrochloride Injection in the Treatment of Acute Urticaria: a Randomized, Double-blind, Positive Controlled, Multicenter Phase III Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol